Alternatives in Cancer Therapy

Targeting Autophagy in Cancer Therapy  eBooks & eLearning

Posted by interes at Nov. 25, 2016
Targeting Autophagy in Cancer Therapy

Targeting Autophagy in Cancer Therapy (Current Cancer Research) by Jin-Ming Yang
English | 2016 | ISBN: 3319427385 | 141 pages | PDF | 4 MB

Matrix Metalloproteinase Inhibitors in Cancer Therapy  eBooks & eLearning

Posted by tanas.olesya at July 15, 2016
Matrix Metalloproteinase Inhibitors in Cancer Therapy

Matrix Metalloproteinase Inhibitors in Cancer Therapy by Neil J. Clendeninn
English | 17 Sept. 2000 | ISBN: 0896036685 | 280 Pages | PDF | 2 MB

Cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies.

Antifolate Drugs in Cancer Therapy  

Posted by MoneyRich at Dec. 11, 2015
Antifolate Drugs in Cancer Therapy

Antifolate Drugs in Cancer Therapy by Ann Jackman
English | 24 Mar. 2013 | ISBN: 1475745214 | 472 Pages | PDF | 13 MB

Antifolates are an important class of anticancer drugs originally developed as anti leu­ kemic agents, but now used, usually in combination with other drugs, for the treatment of a wide range of tumors, notably carcinomas of the head and neck, breast, germ cell tumors, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, and osteogenic sar­ comas. 5-Fluorouracil and its prodrugs also target, in part, the folate-dependent enzyme, thymidylate synthase.
Lipid A in Cancer Therapy (Advances in Experimental Medicine and Biology)

Lipid A in Cancer Therapy (Advances in Experimental Medicine and Biology) by Jean-Francois Jeannin
English | Nov. 18, 2009 | ISBN: 1441916024 | 145 Pages | PDF | 17 MB

Cancer remains a major challenge for modern society. Not only does cancer rank among the first three causes of mortality in most population groups but also the therapeutic options available for most tumor types are limited.
Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development)

Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development) by Youcef M. Rustum
English | Dec. 2, 2002 | ISBN: 0896039560 | 340 Pages | PDF | 5 MB

Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors.

Checkpoint Responses in Cancer Therapy  

Posted by alt_f4 at Sept. 8, 2015
Checkpoint Responses in Cancer Therapy

Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development) by Wei Dai
English | June 6, 2008 | ISBN: 1588299309 | 320 Pages | PDF | 6.5 MB

Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets.
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development) by Wafik S. El-Deiry
English | Dec. 3, 2004 | ISBN: 1588291723 | 387 Pages | PDF | 7 MB

An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes.
Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) by Antonio Giordano
English | Nov. 20, 2002 | ISBN: 0896039307 | 327 Pages | PDF | 2.5 MB

Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases.
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development) by Dennis M. Brown
English | Sep. 8, 2003 | ISBN: 0896038882 | 402 Pages | PDF | 2.5 MB

Leading experts survey the currently available technologies designed to improve the delivery of today's cancer chemotherapeutic agents.
EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development) 2009th Edition

EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development) by John D. Haley
English | Sep. 25, 2008 | ISBN: 1588299481 | 390 Pages | PDF | 4,5 MB

The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies.